EI
MDCO

EAM Investors’s Medicines Co MDCO Stock Holding History

EAM Investors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-33,555
Closed -$1.68M – 360
2019
Q3 		$1.68M Buy
+33,555
New +$1.34M 0.44% 97
2017
Q2 		– Sell
-63,753
Closed -$3.12M – 400
2017
Q1 		$3.12M Buy
+63,753
New +$2.91M 0.49% 68
2015
Q4 		– Sell
-63,432
Closed -$2.41M – 379
2015
Q3 		$2.41M Buy
+63,432
New +$2.23M 0.38% 113

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

EAM Investors's MDCO Position: Q4 2019 in Review

EAM Investors sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 33,555 shares — an estimated $1.68M sold.

EAM Investors first reported a position in MDCO in Q3 2015 and held it in 3 quarters. The position peaked at $3.12M in Q1 2017. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • EAM Investors reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • EAM Investors sold 33,555 Medicines Co shares in Q4 2019, an estimated $1.68M.
  • EAM Investors first reported a position in Medicines Co in Q3 2015 and held it in 3 quarters.
  • EAM Investors's Medicines Co position peaked at $3.12M in Q1 2017.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on EAM Investors's 13F filing for Q4 2019, filed 11 Feb 2020.